Thomas Carlsen holds a Masters in Human Biology and a Ph.D. in Virology from the University of Copenhagen, Denmark. He is working at Novo Nordisk A/S for the past 7 years, both as a scientist and leader within virus safety and process development. Currently, he is a director in Stem Cell R&D at Novo Nordisk A/S bringing the full pipeline to FHD and in the future through the clinical phases.